Janux Therapeutics is developing safe, effective novel immunotherapies with the company’s proprietary TRACTr technology. Janux’s TRACTr technology employs a modular design to rapidly engineer drug candidates against specific targets. 

Biotechnology

Janux Therapeutics

David Campbell

Zachariah McIver

Koho Iizuka

James Pennington

Sheila Gujrathi, MD

Nick Almaguer

Michael Donovan

Lina Ma

Hans Aerni

Yogesh Bramhecha, PhD

Sara Walsh

Natalija Van Braeckel Budimir

Jerry Warren

Carolina Caffaro

Charles Winter

Brenda Van Vreeswyk

Tighe Reardon

Byron Robinson

Shahram Salek-Ardakani

Andy Meyer

The executive team at Janux Therapeutics has a history in investment banking, consulting, and accounting. They have worked for companies such as Evercore, Bank of America Merrill Lynch, and Galt & Company. They have degrees from Georgetown University and the University of Southern California.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Janux Therapeutics

Board of Directors

Leadership Team